#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Toxic epidermal necrolysis Sjogren's syndrome Paraneoplastic neurological syndrome Non-Hodgkin's lymphoma refractory Chronic hepatitis B Chorioretinitis Congenital megacolon Arrhythmogenic right ventricular dysplasia Pancreatic carcinoma metastatic Dermatitis Head and neck cancer Necrotising enterocolitis neonatal Sickle cell anaemia Solitary fibrous tumour More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Basic Information Waldenstrom’s macroglobulinaemia refractory – Trials in Disease CADASIL – Basic Information Breast angiosarcoma – Life with Disease Gaucher’s disease type III – Treatment Encephalitis autoimmune Acquired haemophilia – Treatment Alport’s syndrome – Diagnostics Mucopolysaccharidosis – Basic Information Fragile X syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Water For Injections Promethazine Hydrochloride Gimeracil Levothyroxine Sodium Cefepime Hydrochloride GSK3862995B Sertraline Hydrochloride Anv600 Simeticone Giroctocogene Fitelparvovec Efinopegdutide Orlistat Ixazomib Citrate Tamoxifen Citrate Anhydrous Glucose Bp SOVATELTIDE Paclitaxel Albumin-Bound Elraglusib Human Serum Albumin 5% Psilocybine More therapies…

    Learn about Your Condition

    Appendicitis perforated Hyperoxaluria Peptostreptococcus infection Apathy Metastatic gastric cancer Frostbite Chondroplasty Myelodysplastic syndrome Adenocarcinoma Brain cancer metastatic Sepsis Langerhans' cell histiocytosis Immune-mediated enterocolitis Left ventricular dysfunction Kawasaki's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study of Intrathecal Cebsulfase Alfa for Children with Late Infantile Metachromatic Leukodystrophy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metachromatic leukodystrophy
    Investigated Drugs:
    • Cebsulfase Alfa
    Belgium France Germany Greece Italy Spain

  • Long-Term Safety Study of Fenfluramine Hydrochloride for Seizures in Patients with Dravet or Lennox-Gastaut Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • Fenfluramine Hydrochloride
    Italy The Netherlands Poland Spain

  • Study on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    The Netherlands

  • Study on Cerebrolysin and Sodium Chloride for Patients with CADASIL

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Arterial disorder
    • Leukoencephalopathy
    Investigated Drugs:
    • Cerebrolysin Concentrate
    • Sodium Chloride
    Czechia

  • Study on the Safety and Efficacy of CLS12311 and Autologous Red Blood Cells for Patients with Relapsing Remitting Multiple Sclerosis

    Not recruiting

    1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Cls12311
    Czechia Germany Italy

  • Study of sulthiame combined with oral appliance therapy for patients with obstructive sleep apnea who have incomplete response to oral appliance treatment alone

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Investigated Drugs:
    • Sultiame
    Denmark Sweden
Previous Page
1 … 103 104 105 106 107 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!